← Back to Search

Implant

Clavicle Plate for Collarbone Fracture

N/A
Waitlist Available
Research Sponsored by Zimmer Biomet
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patient must have a clavicle fracture requiring surgical intervention and be eligible for fixation by locking plate and screws
Patient must be 18 years of age or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Study Summary

This trial looks at the safety and effectiveness of a clavicle plate for treating broken collarbones.

Who is the study for?
This trial is for adults over 18 with a broken collarbone needing surgery. They must understand and follow the study's procedures and agree to all follow-ups. It's not for those unable or unwilling to consent, prisoners, pregnant or breastfeeding individuals, people unlikely to complete the follow-up, with active infections, metal sensitivities without prior testing, poor bone quality/quantity, or substance abuse issues.Check my eligibility
What is being tested?
The A.L.P.S. Clavicle Plating System PMCF trial tests the safety and effectiveness of a clavicle plating system used in surgical repair of collarbone fractures. The focus is on how well both the implant and surgical instruments work during this procedure.See study design
What are the potential side effects?
While specific side effects are not listed here, typical risks from such surgeries may include pain at the site of surgery, infection risk due to implantation of foreign material into the body, possible allergic reactions if there's an undetected metal sensitivity.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I need surgery for my broken clavicle using a plate and screws.
Select...
I am 18 years old or older.
Select...
I have a fracture in one or both of my limbs.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of subjects with fracture healing
Secondary outcome measures
Clinical efficacy of the device is assessed using the American Shoulder and Elbow Surgeons (ASES) Shoulder Score at 12 months follow-up
Euroqol Patient Quality of life measured at 12 months follow-up (EQ-5D-5L)
Frequency and Incidence of Adverse Events (Safety)
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Treatment GroupExperimental Treatment1 Intervention
The population target is all subjects suffering clavicle fracture suitable for open reduction and internal fixation by the A.L.P.S. Clavicle Plating System in accordance with the IFU.

Find a Location

Who is running the clinical trial?

Zimmer BiometLead Sponsor
373 Previous Clinical Trials
67,299 Total Patients Enrolled

Media Library

ALPS Clavicle Plating System (Implant) Clinical Trial Eligibility Overview. Trial Name: NCT05327959 — N/A
Collarbone Fracture Research Study Groups: Treatment Group
Collarbone Fracture Clinical Trial 2023: ALPS Clavicle Plating System Highlights & Side Effects. Trial Name: NCT05327959 — N/A
ALPS Clavicle Plating System (Implant) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05327959 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are enrollment opportunities open for this experimentation?

"Clinicaltrials.gov divulges that this medical study, posted on May 13th 2022 and last updated August 10th 2022, is not currently recruiting participants. Nonetheless, there are presently 349 other trials actively looking for patients to join their program."

Answered by AI
~48 spots leftby Mar 2026